Article source: Siyu MedTech; Editor: Bai Xiaofei
Reprint requirements: It can be reprinted 24 hours after the first release, and the source must be indicated
In recent years, three new forces have entered the medical device field, including medicine, IT (including the Internet), and traditional manufacturing. Internet giants including Tencent , Ali , Baidu , Meituan , Kuaishou, Xiaomi , etc., all have layouts for medical devices, or invest in medical device companies through investment; or enter the medical service industry, or use their own traffic to become a new channel for household medical devices , thus entering the growing medical device market.
The medical device industry is still very threshold. Its profit and growth speed are far inferior to the Internet, and the overall industry scale is much lower than that of food, clothing, housing and transportation.
requires perseverance, patience and caution in making equipment.
After Internet manufacturers enter from home medical devices and medical services, will they gradually enter the third category of products and lead hospital medical devices, and will they go deeper into the medical device industry?
follow-up performance, wait and see. This issue will sort out the actions of each company for readers' reference.
# 01 Tencent
(Source: Tencent official website)
Tencent has long been in the medical field. In addition to the attempts in its own fields such as " Tencent Miying ", "Penguin Medical Document", and "Teng Ai Doctor", from 2014 to the present, Tencent has invested as much as 353 in the medical field. It is worth noting that Tencent has successively reduced its holdings in many listed companies such as , JD.com, SeaLimited, New Oriental , etc. This year, and has begun to invest funds in projects including Gengmei, WeDoctor , Xinyang , Dingxiangyuan , Haodafu, Huiyi Online, Doctor Neighbor Doctor, Robin, Doctor Miaoshou, Penguin Almond , Senyi Intelligence and other projects.
Previously, Xunjie Medical, a wholly-owned subsidiary of Yuyue Medical, planned to introduce strategic investors - Shenzhen Shechuang Xiangshan Technology Co., Ltd., by increasing capital and expanding shares, behind it is Tencent. Tencent subscribed to Xunjie Medical's new registered capital with cash of 291 million yuan. After the completion of this capital increase, Xunjie Medical's registered capital increased from 150 million yuan to 186 million yuan.
Xunjie Medical mainly engages in first aid business. Its subsidiary of Germany's Pumeikang has more than 40 years of experience in the field of medical first aid. Its semi-automatic external cardiac defibrillator and cardiac defibrillation monitoring products have a high reputation in the global medical first aid industry. As early as 2017, it was acquired by Yuyue Medical . Yuyue Medical said that Tencent’s strategic investment this time will provide financial support for its future production, R&D and operation, and on the other hand, it will also improve the efficiency of its asset operation and promote the expansion of the company’s first aid segment business.
Not only that, in March 2022, Guangxi Tencent Venture Capital Co., Ltd. acquired a stake in Shenzhen Saihe Medical Technology Co., Ltd., and Tencent officially entered the third category of interventional medical devices and laid out the cardiovascular field. The fully automatic peripheral blood cell morphology analyzer jointly developed by Tencent AI Lab and Mindray Medical has also officially entered the NMPA innovation channel. Tencent AI Lab also jointly released a portable intelligent surgical navigation system with independent property rights with Peking Union Medical College Hospital , and its initial clinical application has been successful.
# 02 Alibaba
(Source: Alibaba official website)
Among many giants, Alibaba is an early player to explore the medical field. Relying on Taobao, Tmall , Alipay and other flagship products, combined with investment layout, Alibaba has made many moves in the medical field.
As early as January 2014, Alibaba held CITIC 21st Century Co., Ltd. for US$171 million, and then changed its name to "Ali Health ". Since then, Alibaba Health has entered the medical e-commerce field by acquiring Guangzhou 5,000-year-old pharmaceutical chain and Blue Hat health food business.Alibaba leverages its advantages in e-commerce, cloud computing , financial technology and other fields to collaborate with resources such as Taobao, Tmall, Alibaba Cloud , Alipay, and focus on the B-side operation to achieve coordinated development between users and the medical industry.
Specifically at the technical level, Alibaba Cloud provides support in medical AI, Internet hospitals, medical informatization and other fields, such as introducing deep learning into the fields of intelligent medical diagnosis and medical data analysis, and is applied to medical clinical prevention, diagnosis, treatment and other links.
In addition to Alibaba Health, the new retail giant Hema under Alibaba has also joined the medical device sales camp. It is understood that Shenzhen Hema has added wholesale and retail business of Class III medical devices in addition to its previous business scope of Class II medical devices. It is reported that in the past two years, Hema has made intensive arrangements in the fields of medicine and medical devices, and has successively obtained drug and medical device business licenses, and even medical device production licenses.
# 03 JD
(Source: JD official website)
In 2019, JD medical department was officially changed to JD Health , announcing its independent operation, and its subsidiary integrates JD's pharmaceutical retail, pharmaceutical wholesale, healthy city and other business segments, aiming to build the third largest brand business after JD Digital Technology and JD Logistics . JD Health is JD Group’s key layout in the medical field, and has successively received US$931 million in Series A financing and US$830 million in Series B financing. Based on JD Pharmacy, JD Health focuses on starting from the pharmaceutical retail end, and then gradually expands into the field of in-depth pharmaceutical services and Internet medical services. It is JD's third "unicorn" under JD.com.
Previously, JD Health and Yuyue Medical signed a strategic cooperation agreement for . Based on the good cooperation, the two parties will further strengthen cooperation in data interoperability, C2M customization, category expansion, and global marketing, relying on JD Health's advantages in medical health supply chain, medical health service capabilities, and Yuyue 's technology and service capabilities in the field of medical devices, and jointly build a "product + service" health management solution.
# 04 Baidu
(Source: Baidu official website)
2019, Baidu Online Network Technology (Beijing) Co., Ltd. changed its business scope and increased the second and third types of sales of medical devices, and invested in Neusoft Medical on March 19.
In October 2020, the life science platform company BioMap (English abbreviation "BioMap") was officially established. Baidu founder, chairman and CEO Li Yanhong is confirmed to be the lead initiator and personally serve as the chairman of the new company. BV Baidu Venture Capital CEO Liu Wei serves as co-founder and serves as the CEO of Baitu Biotech. Information on
official website shows that Baitu Biotech plans to invest tens of billions of yuan to build an independent and controllable biological computing platform, using cutting-edge algorithms, intelligent sensors , smart chips, micro-nano robots and other AI capabilities to solve life science problems. Utilize technology + capital to accelerate the research and development of precise life science products such as drug design, target discovery, and precise diagnosis digital medical care.
In August 2022, Baidu successfully entered the list of innovation tasks of artificial intelligence medical device with the first domestic fundus auxiliary diagnosis software that entered the registration and review stage.
# 05 Huawei
(Source: Huawei official website)
Huawei's layout in the medical field focuses more on giving full play to its own communication technology and hardware capabilities advantages.
On the B-side, Huawei focuses on promoting the application and implementation of new technologies such as 5G, cloud computing, artificial intelligence, and the Internet of Things in the medical field, and emphasizes personalized customization with cooperative medical institutions. Huawei Medical mainly involves digital hospitals, regional health informationization, tiered diagnosis and treatment ; digital hospital business includes mobile medical care, digital hospital network and small and medium-sized hospital network; regional medical information platform includes virtualized cloud platform, health file full life cycle management , cloud network and other innovative ICT solutions; tiered diagnosis and treatment includes a new ICT architecture based on medical collaboration, cloud sharing, and open compatibility, and working with partners to build tiered diagnosis and treatment solutions.
is aimed at the C-end, and Huawei focuses more on the research and development and application of medical devices and wearable equipment. In March 2019, Huawei officially entered the medical device industry and laid out Huawei medical smart wearable equipment and smart watch . Currently, is creating a digital health ecosystem that seamlessly coordinates software and hardware and services. The hardware includes smart watches, smart bracelets, children's watches , innovative terminals, and smart selection products; services include healthy life, dietary health, scientific exercise, chronic disease management, and cooperative services; efficient collaboration of software and hardware and services through big data algorithms.
Recently, the research on innovative blood sugar, lung function health, plateau health, etc.
2html In September 2022, Huawei ECG App (Huawei ECG Analysis Prompt Software) obtained EU CE MDR medical device certification and obtained a pass to enter the EU and European Trade Free Zone national markets. At present, Huawei ECG App has obtained market access qualifications in 33 European countries. In the future, consumers in Europe will be able to use the ECG App to perform single-lead ECG measurements in HUAWEI WATCH GT 3 Pro one after another.
In fact, Huawei has more medical device layouts for hospitals. For example, artificial intelligence assisted pathological diagnosis products and large-scale equipment such as medical heavy ion accelerators. (In January 2022, Huawei and Guoke Holdings and Chinese Institute of Modern Materials Science Institute of Science and Technology - Lanzhou Kejintaiji announced that it would jointly promote the research and development and application of carbon ion therapy systems in the medical industry.)
# 06 ByteDance
(Source: ByteDance official website)
Currently, ByteDance's medical map includes online medical popularization, digital consultation, diagnosis and appointment, offline medical clinics, etc., covering drug research and development, pathological testing, offline institutions and other diagnosis and treatment links. In terms of product , has the " colonoscopy AI assisted diagnosis software"; it also entered the synthetic biology company through investment.
In August 2020, ByteDance completed the full acquisition of the encyclopedia famous doctor (later renamed "Xiaohe Medical Dictionary"). In December 2020, Byte acquired Wu Haifeng, the former vice president of Baidu, and established an Aurora department specializing in the big health business.
In September 2021, ByteDance invested in three companies in the medical and health field, namely the U.S.-China Yihe and Hongda Airehe Medical and Health Platform "Good Mood", covering fields including obstetrics and pediatrics, tumor treatment, mental health, etc.
In November 2021, Xiaohe Medical Devices (Hainan) Co., Ltd. was established, including the production of first-class medical devices, the sales of second-class medical devices, the sales of special chemical products, and the development of artificial intelligence application software.
In December 2021, Shanghai Diying Biotechnology Co., Ltd. (Diying Biotechnology) received strategic investments from Hansen (Shanghai) Health Technology Co., Ltd., Boyu Capital and ByteDance. Diying Bio has developed a breakthrough high-throughput DNA synthesis platform and QuarXeq double-strand RNA probe capture technology for the first time in China, achieving a zero breakthrough in the first in-situ synthetic gene chip in China.
# 07 Meituan
(Source: Meituan official website)
In November 2021, Cornerstone Robotics, a leader in innovative surgical robotics technology, announced that it had completed a 500 million yuan B round financing, introducing many well-known investment institutions , including Eli Lilly Asia Fund, Meituan Dragon Ball and New World Development Group, old shareholders Qiming Venture Capital, Qingsong Capital, Gaorong Capital and Xianfeng K2VC continue to invest additionally.
The bid-beared financing is mainly used for surgical robot product research and development, clinical trials, marketing promotion, new product layout and industry cutting-edge technology platform construction. According to public information, this is Meituan’s first entry into the medical robot track since entering the medical device industry in 2019.
Recently, Shanghai Sankuai Technology Co., Ltd., invested by Meituan, invested in Shenzhen Baishou Health Information Technology Co., Ltd. From the perspective of the company's business scope, it includes the sales of Class II and Class II medical devices .
# 08 Xiaomi
(Source: Xiaomi official website )
Xiaomi mainly enters the medical and health field through its own business model of "hardware + Internet + new retail".
As early as 2014, Xiaomi invested US$25 million (approximately RMB 175 million) to invest in Ji'an Medical and has begun to expand into the medical and health field. Xiaomi's investment means that iHealth can enter Xiaomi's resource system and cooperate in user experience, sales channels, and cloud services. It was not until December 2019 that Xiaomi's wholly-owned subsidiary Shile Technology announced a change in its business scope, adding a new "medical internal medicine and medical services" project to its original business, and Xiaomi began to officially enter the medical and health field.
In July 2021, inFace, a "beauty artifact" company led by Lei Jun , received tens of millions of yuan in Pre-A round of financing. The last round of investment in Fangxinpao Capital and strategic partners added investment. This round of financing represents inFace officially joining Xiaomi's ecosystem chain, and inFace is still actively preparing for the next round of financing.
inFace was launched on the Xiaomi Youpin e-commerce platform in 2017 and launched a sonic ion cleanser in January 2018. Subsequently, inFace launched cleanser , gold beauty stick, blackhead instrument, straight hair comb and other products, which has long been at the forefront of the cleaning and care list of Xiaomi Youpin e-commerce platform.
# 09 Kuaishou
(Source: Kuaishou official website)
Chengdu Kuaishou was established in 2019 and is wholly owned by Beijing Kuaishou Technology Co., Ltd. . In 2021, Chengdu Kuaigou Technology Co., Ltd. added a new "class 3 medical device operation" in its business scope. In addition, as early as March 2021, the company's industrial and commercial information changed, and its business scope added health consulting services, sales of second-class medical devices, and sales of first-class medical devices, and officially entered the medical device industry.
# 10 Dingding
(Source: Dingding official website)
In April 2020, Dingding (China) Information Technology Co., Ltd. changed its business scope, and the new business was the sales of Class II medical devices; the sales of Class I medical devices; the sales of needle textiles and raw materials; the sales of animation and amusement supplies, etc. It is reported that the newly added medical qualifications are mainly used to launch the new coronavirus nucleic acid testing service. The institution that cooperated with DingTalk to conduct nucleic acid testing is Dian Diagnostics, a third-party medical testing company.
As more and more cross-border giants join the medical industry, competition among enterprises has further intensified. This not only means that my country's medical device technological innovation capabilities will be improved, but also means that the traditional marketing model of the medical device market has begun to be broken, and the addition of new retail channels such as e-commerce will bring about a huge change.
